Modification of lipid-based nanoparticles: An efficient delivery system for nucleic acid-based immunotherapy C Zhang, Y Ma, J Zhang, JCT Kuo, Z Zhang, H Xie, J Zhu, T Liu Molecules 27 (6), 1943, 2022 | 36 | 2022 |
CpG oligodeoxynucleotides for anticancer monotherapy from preclinical stages to clinical trials Z Zhang, JCT Kuo, S Yao, C Zhang, H Khan, RJ Lee Pharmaceutics 14 (1), 73, 2021 | 36 | 2021 |
Investigating the effects of erythrosine B on amyloid fibril formation derived from lysozyme CT Kuo*, YL Chen*, WT Hsu, SC How, YH Cheng, SS Hsueh, HS Liu, ... International journal of biological macromolecules 98, 159-168, 2017 | 20 | 2017 |
A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors R Robb, JCT Kuo, Y Liu, S Corrales-Guerrero, T Cui, A Hegazi, G Nagy, ... Molecular Therapy-Oncolytics 22, 555-564, 2021 | 10 | 2021 |
AZD5153, a Bivalent BRD4 Inhibitor, Suppresses Hepatocarcinogenesis by Altering BRD4 Chromosomal Landscape and Modulating the Transcriptome of HCC Cells CH Lin*, JCT Kuo*, D Li, AB Koenig, A Pan, P Yan, XF Bai, RJ Lee, ... Frontiers in Cell and Developmental Biology, 661, 2022 | 8 | 2022 |
A squalene-based nanoemulsion for therapeutic delivery of resiquimod Z Zhang, JCT Kuo, C Zhang, Y Huang, Z Zhou, RJ Lee Pharmaceutics 13 (12), 2060, 2021 | 8 | 2021 |
Ivermectin Enhanced Antitumor Activity of Resiquimod in a Co-loaded Squalene Emulsion Z Zhang*, JCT Kuo*, C Zhang, Y Huang, RJ Lee Journal of Pharmaceutical Sciences, 2022 | 5 | 2022 |
Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles Z Zhang, Y Huang, J Li, F Su, JCT Kuo, Y Hu, X Zhao, RJ Lee Advanced Healthcare Materials 12 (6), 2202412, 2023 | 4 | 2023 |
Improved Targeting and Safety of Doxorubicin through a Novel Albumin Binding Prodrug Approach Y Liu, S Corrales-Guerrero, JC Kuo, R Robb, G Nagy, T Cui, RJ Lee, ... ACS omega 9 (1), 977-987, 2023 | 1 | 2023 |
Correction to: methods used to make lipid nanoparticles to deliver LNA gapmers against lncRNAs into acute myeloid leukemia (AML) blasts JCT Kuo, RJ Lee, R Garzon Long Non-Coding RNAs in Cancer, C1-C1, 2021 | 1 | 2021 |
Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer’s disease A Badr, KP Daily, M Eltobgy, S Estfanous, MH Tan, JCT Kuo, O Whitham, ... Brain, Behavior, and Immunity 119, 919-944, 2024 | | 2024 |
Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma C Zhang*, JCT Kuo*, Y Huang, Y Hu, L Deng, BC Yung, X Zhao, Z Zhang, ... Pharmaceutics 15 (12), 2674, 2023 | | 2023 |
Methods Used to Make Lipid Nanoparticles to Deliver LNA Gapmers Against lncRNAs into Acute Myeloid Leukemia (AML) Blasts JCT Kuo, RJ Lee, R Garzon Long Non-Coding RNAs in Cancer, 167-174, 2021 | | 2021 |